DNMT3A-mutated CHIP was more common in prevalent seropositive RA in the FinnGen study, and patients with newly diagnosed seropositive RA with DNMT3A mutations had higher DAS28 disease severity score as well as higher ESR. Here, DNMT3A is linked to rheumatoid arthritis.